Instrument Inactif

Transcripts PDL BioPharma, Inc.

Actions

PDLI

US69329Y1047

Recherche biotechnologique et médicale

Transcripts

11/11/20	Transcript : PDL BioPharma, Inc., Q3 2020 Earnings Call, Nov 11, 2020
10/09/20	Transcript : PDL BioPharma, Inc. - Special Call
10/09/20	PDL BioPharma, Inc. fournit des prévisions de revenus pour 2022	CI
19/08/20	Transcript : PDL BioPharma, Inc. - Shareholder/Analyst Call
06/08/20	Transcript : PDL BioPharma, Inc., Q2 2020 Earnings Call, Aug 06, 2020
07/05/20	Transcript : PDL BioPharma, Inc., Q1 2020 Earnings Call, May 07, 2020
11/03/20	Transcript : PDL BioPharma, Inc., Q4 2019 Earnings Call, Mar 11, 2020
09/12/19	Transcript : PDL BioPharma, Inc. - Special Call
06/11/19	Transcript : PDL BioPharma, Inc., Q3 2019 Earnings Call, Nov 06, 2019
07/08/19	Transcript : PDL BioPharma, Inc., Q2 2019 Earnings Call, Aug 07, 2019
21/05/19	Transcript : PDL BioPharma, Inc. Presents at UBS Global Healthcare Conference 2019, May-21-2019 08:30 AM
09/05/19	Transcript : PDL BioPharma, Inc., Q1 2019 Earnings Call, May 09, 2019
14/03/19	Transcript : PDL BioPharma, Inc., Q4 2018 Earnings Call, Mar 14, 2019
06/11/18	Transcript : PDL BioPharma, Inc., Q3 2018 Earnings Call, Nov 06, 2018
08/08/18	Transcript : PDL BioPharma, Inc., Q2 2018 Earnings Call, Aug 08, 2018
22/05/18	Transcript : PDL BioPharma, Inc. Presents at 2018 UBS Global Healthcare Conference, May-22-2018 11:30 AM
09/05/18	Transcript : PDL BioPharma, Inc., Q1 2018 Earnings Call, May 09, 2018
08/03/18	Transcript : PDL BioPharma, Inc., Q4 2017 Earnings Call, Mar 08, 2018
02/11/17	Transcript : PDL BioPharma, Inc., Q3 2017 Earnings Call, Nov 02, 2017
03/08/17	Transcript : PDL BioPharma, Inc., Q2 2017 Earnings Call, Aug 03, 2017
03/05/17	Transcript : PDL BioPharma, Inc., Q1 2017 Earnings Call, May 03, 2017
01/03/17	Transcript : PDL BioPharma, Inc., Q4 2016 Earnings Call, Mar 01, 2017
03/11/16	Transcript : PDL BioPharma, Inc., Q3 2016 Earnings Call, Nov 03, 2016
04/08/16	Transcript : PDL BioPharma, Inc., Q2 2016 Earnings Call, Aug 04, 2016
06/07/16	Transcript : PDL BioPharma, Inc. - Special Call